{
  "alleleExist":false,
  "dataVersion":"v4.5",
  "diagnosticImplications":[
    {
      "abstracts":[],
      "alterations":[
        "Oncogenic Mutations"
      ],
      "description":"",
      "levelOfEvidence":"LEVEL_Dx3",
      "pmids":[
        "24317090",
        "29288042",
        "22859607",
        "22591296",
        "25281507"
      ],
      "tumorType":{
        "children":{},
        "code":"TLGL",
        "color":"LimeGreen",
        "id":488,
        "level":5,
        "mainType":{
          "id":null,
          "name":"Mature T and NK Neoplasms",
          "tumorForm":"LIQUID"
        },
        "name":"T-Cell Large Granular Lymphocytic Leukemia",
        "parent":"MTNN",
        "tissue":"Lymphoid",
        "tumorForm":"LIQUID"
      }
    }
  ],
  "diagnosticSummary":"",
  "geneExist":true,
  "geneSummary":"STAT3, a transcription factor, is altered by mutation or amplification in various solid and hematologic malignancies.",
  "highestDiagnosticImplicationLevel":"LEVEL_Dx3",
  "highestFdaLevel":null,
  "highestPrognosticImplicationLevel":null,
  "highestResistanceLevel":null,
  "highestSensitiveLevel":null,
  "hotspot":true,
  "lastUpdate":"02/06/2023",
  "mutationEffect":{
    "citations":{
      "abstracts":[],
      "pmids":[
        "23872306",
        "29378236"
      ]
    },
    "description":"The STAT3 E616del mutation is located in the SH2 domain of the protein. This mutation has been identified in diffuse large B-cell lymphoma and is a statistically significant hotspot (PMID: 23872306). In vitro studies with HEK293T cells expressing STAT3 E616del demonstrate that the mutation is activating as measured by increased reporter activity in non-stimulated conditions compared to wildtype (PMID: 29378236).",
    "knownEffect":"Likely Gain-of-function"
  },
  "oncogenic":"Likely Oncogenic",
  "otherSignificantResistanceLevels":[],
  "otherSignificantSensitiveLevels":[],
  "prognosticImplications":[],
  "prognosticSummary":"",
  "query":{
    "alteration":"E616del",
    "alterationType":null,
    "consequence":"inframe_deletion",
    "entrezGeneId":6774,
    "hgvs":"17:g.42323043_42323045del",
    "hugoSymbol":"STAT3",
    "id":null,
    "proteinEnd":617,
    "proteinStart":616,
    "referenceGenome":"GRCh38",
    "svType":null,
    "tumorType":null
  },
  "treatments":[],
  "tumorTypeSummary":"",
  "variantExist":true,
  "variantSummary":"The STAT3 E616del alteration is likely oncogenic.",
  "vus":false
}